WallStSmart
PASG

Passage Bio Inc

NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY

$5.11
-4.49% today

Updated 2026-04-30

Market cap
$18.32M
P/E ratio
P/S ratio
EPS (TTM)
$-14.35
Dividend yield
52W range
$5 – $20
Volume
0.1M

WallStSmart proprietary scores

30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$11.40
+123.09%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-6.48M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-136.13M$-102.06M$-64.77M$-45.52M$-12.98M
EPS$-14.35
Free cash flow$-123.48M$-78.41M$-47.99M$-31.51M$-6.48M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PASG$18.32M304.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Passage Bio Inc trades at $5.11. Our Smart Value Score of 30/100 indicates the stock is weak.

Frequently asked questions

What is Passage Bio Inc's stock price?
Passage Bio Inc (PASG) trades at $5.11.
Is Passage Bio Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Passage Bio Inc (PASG)?
The analyst target price is $11.40, representing +123.1% upside from the current price of $5.11.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-113.80%
Beta1.77
50D MA$8.27
200D MA$8.64
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years